Menu Back toSession-0605-ChP-Townhall

The 7th DIA China Annual Meeting


Session 0605 ChP Townhall

Session Chair(s)

Yi  REN, PhD, MBA

Yi REN, PhD, MBA

  • General Manager
  • Nanjing Medichem Bio-Pharmaceutical Development Co. , China

Change of ChP 2015 and Future Direction

Speaker(s)

Wei  Zhang

Wei Zhang

  • CFDA, China
Wei  Zhang

Change of ChP 2015 and Future Direction

Wei Zhang

  • Director General, Department of Drug Registration, CFDA, China
  • CFDA, China, China
Kevin  Cao

USP&PDG_Pharmacopeial Discussion Group’s Perspective on Harmonization (EN&CN)

Kevin Cao

  • User Relationship Management, USP
  • USP, China
Melly  Lin

Industry’s Perspective on Pharmacopeia Harmonization and collaboration

Melly Lin

  • Senior Regulatory Manager, CMC Policy,
  • Roche(China) Holding Ltd, China

Contact us

For exhibition, advertising and hosting inquiry, please contact:
Jean XU: jxu@kellencompany.com, or Sofie Peeters: speeters@kellencompany.com
Tel: +86 10 5923 1096

For general inquiry, please contact DIA China office:
dia@diachina.org
Tel: +86 10 5704 2650